Exonucleases Market, By Product Type (Single-stranded exonucleases and Double-stranded exonucleases), By Enzyme Type (5’→3’ Exonucleases, 3\'→ 5\' exonucleases, Dual-Activity Exonucleases, Proofreading Exonucleases, Mismatch Repair Exonucleases, and Restriction-Associated Exonucleases), By Source (Prokaryotic Exonucleases, Eukaryotic Exonucleases, Viral Exonucleases, and Recombinant/Synthetic Exonucleases), By Product Format (Reagents and Kits and Instruments and Systems), By Reaction Specificity (DNA-Specific Exonucleases, RNA-Specific Exonucleases, and DNase/RNase Dual-Specific Exonucleases), By Application (PCR Cleanup, DNA Sequencing Workflows, RNA Sequencing Workflows, Cloning and Molecular Cloning Workflows, Genome Editing Protocols, DNA Repair and Mismatch Repair Studies, Protein–Nucleic Acid Interaction Studies, Diagnostic Assays, and Biopharmaceutical R and D Workflows), By End User (Academic and Research Institutes, Biotechnology Companies, Pharmaceutical Companies, Clinical and Diagnostic Laboratories, and Contract Research Organizations), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)